HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shuhei Nakao Selected Research

1- (2- (2- methoxyphenylamino)ethylamino)- 3- (naphthalene- 1- yloxy)propan- 2- ol

3/2015The newly synthesized anticancer drug HUHS1015 is useful for treatment of human gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shuhei Nakao Research Topics

Disease

2Neoplasms (Cancer)
03/2021 - 03/2015
2Necrosis
03/2018 - 03/2015
1Drug-Related Side Effects and Adverse Reactions
01/2022
1Heart Failure
01/2022
1Multiple Myeloma
01/2022
1Stomach Neoplasms (Stomach Cancer)
03/2015
1Adenocarcinoma
03/2015
1Hyperplasia
03/2015

Drug/Important Bio-Agent (IBA)

1carfilzomibIBA
01/2022
1Proteasome InhibitorsIBA
01/2022
1alpha-Linolenic Acid (Linolenic Acid)IBA
03/2021
1Fas Ligand Protein (Fas Ligand)IBA
03/2018
1naftopidilIBA
03/2015
1Irinotecan (Camptosar)FDA LinkGeneric
03/2015
11- (2- (2- methoxyphenylamino)ethylamino)- 3- (naphthalene- 1- yloxy)propan- 2- olIBA
03/2015
1Propidium (Propidium Iodide)IBA
03/2015
1Paclitaxel (Taxol)FDA LinkGeneric
03/2015
1Annexin A5IBA
03/2015
1CaspasesIBA
03/2015
1Cisplatin (Platino)FDA LinkGeneric
03/2015
1Pharmaceutical PreparationsIBA
03/2015

Therapy/Procedure

1Aftercare (After-Treatment)
01/2022